#ACR24 - Day 3 Report Highlights from Day 3 at ACR24 included the plenary session presentation on Nipocalimab (previously reviewed), but the big highlight was the Lupus Nephritis guideline recommendations. https://t.co/Dif4EUi30b https://t.co/4hfEJ1ef73